Ooi G C, Mok M Y, Tsang K W T, Wong Y, Khong P L, Fung P C W, Chan S, Tse H F, Wong R W S, Lam W K, Lau C S
Department of Diagnostic Radiology, The University of Hong Kong, Queen Mary Hospital, SAR China.
Acta Radiol. 2003 May;44(3):258-64. doi: 10.1080/j.1600-0455.2003.00058.x.
To evaluate high-resolution CT (HRCT) parameters of inflammation and fibrosis in systemic sclerosis (SSc), for correlation with lung function, skin scores and exercise tolerance.
45 SSc patients (40 women, 48.5+/-13.4 years), underwent thoracic HRCT, lung function assessment, and modified Rodnan skin scores. Exercise tolerance was also graded. HRCT were scored for extent of 4 HRCT patterns of interstitial lung disease (ILD): ground glass opacification (GGO), reticular, mixed and honeycomb pattern in each lobe. Total HRCT score, inflammation index (GGO and mixed score) and fibrosis index (reticular and honeycomb scores) were correlated with lung function and clinical parameters.
ILD was present in 39/45 (86.7%) patients. Abnormal (<80% predicted) forced vital capacity (FVC), total lung capacity (TLC) and carbon monoxide diffusion factor (DLco) were detected in 30%, 22% and 46% of patients. Total HRCT score correlated with FVC (r=-0.43, p=0.008), FEV1 (forced expiratory volume) (r=-0.37, p=0.03), TLC (r=-0.47, p=0.003), and DLCO (r=-0.43, p=0.008); inflammatory index with DLCO (r=-0.43, p=0.008) and exercise tolerance (r=-0.39, p < 0.05); and fibrosis index with FVC (r=-0.31, p=0.05) and TLC (r=-0.38, p=0.02). Higher total HRCT score, and inflammation and fibrosis indices were found in patients with abnormal lung function.
Qualitative HRCT is able to evaluate inflammation and fibrosis, showing important relationships with diffusion capacity and lung volume, respectively.
评估系统性硬化症(SSc)中炎症和纤维化的高分辨率CT(HRCT)参数,以与肺功能、皮肤评分和运动耐力进行相关性分析。
45例SSc患者(40例女性,年龄48.5±13.4岁)接受了胸部HRCT、肺功能评估和改良Rodnan皮肤评分。运动耐力也进行了分级。对HRCT的间质性肺疾病(ILD)的4种HRCT模式(磨玻璃影(GGO)、网状、混合和蜂窝状模式)在每个肺叶中的范围进行评分。总HRCT评分、炎症指数(GGO和混合评分)和纤维化指数(网状和蜂窝状评分)与肺功能和临床参数进行相关性分析。
39/45(86.7%)例患者存在ILD。30%、22%和46%的患者检测到异常(<预测值80%)的用力肺活量(FVC)、肺总量(TLC)和一氧化碳弥散因子(DLco)。总HRCT评分与FVC(r=-0.43,p=0.008)、FEV1(用力呼气量)(r=-0.37,p=0.03)、TLC(r=-0.47,p=0.003)和DLCO(r=-0.43,p=0.008)相关;炎症指数与DLCO(r=-0.43,p=0.008)和运动耐力(r=-0.39,p<0.05)相关;纤维化指数与FVC(r=-0.31,p=0.05)和TLC(r=-0.38,p=0.02)相关。肺功能异常的患者总HRCT评分、炎症和纤维化指数更高。
定性HRCT能够评估炎症和纤维化,分别显示与弥散能力和肺容积的重要关系。